BetterLife Pharma Inc (OTCMKTS: BETRF) has announced positive results after a BETR-001 Preclinical neuroplasticity study in rat neurons. This study was in partnership with Dr. Argel...
BetterLife Pharma Inc. (OTCMKTS: BETRF) has announced that its subsidiary Altum Pharmaceuticals Inc. and Pontifical Universidad Catolica de Chile have finalized the Phase 1 part of...
Betterlife Pharma Inc. (OTCMKTS: BETRF) has announced receipt of the first neurological receptor functional binding data set in its flagship compound, 2-Bromo-LSD (TD-0148A) TD-0148A is a...
BetterLife Pharma Inc. (OTCMKTS: BETRF) has announced positive in-vitro data from Dr. Stephen Barr’s Lab at the ultra-modern ImPaKT Facility at Western University Schulich School of...
BetterLife Pharma Inc (OTCMKTS: BETRF) has announced that it has registered its first patient for the Phase 1 part of Phase 1-2 randomized placebo-controlled in COVID-19...
BetterLife Pharma Inc (OTCMKTS: BETRF), in a statement, announced that it has entered into a formal agreement with the Laboratory of Dr. John McCorvy at the...
BetterLife Pharma Inc (OTCMKTS: BETRF) recently updated about funding from the Mitacs Accelerate program in response to its joint application and the Department of Neuroscience, Carleton...
